Yingying Shi
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 7
- Immunology top 5%
- Immunotherapy and Immune Responses 17
- Phagocytosis and Immune Regulation 6
- Endocrinology top 5%
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 14
- Pharmacology top 5%
-
- Nanoplatforms for cancer theranostics 8
-
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 6
-
- Endoplasmic Reticulum Stress and Disease 5
In The Last Decade
Yingying Shi
84 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Medicine 165
- Immunology 497
- Endocrinology 72
- Molecular Biology 942
- Pharmacology 111
Countries citing papers authored by Yingying Shi
This map shows the geographic impact of Yingying Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingying Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingying Shi more than expected).
Fields of papers citing papers by Yingying Shi
This network shows the impact of papers produced by Yingying Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingying Shi. The network helps show where Yingying Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingying Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 26 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 51 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 16 | |
| 19 | 2013 | 35 | |
| 20 | 2011 | 2 |
About Yingying Shi
Yingying Shi is a scholar working on Molecular Medicine, Immunology and Endocrinology, having authored 90 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), RNA Interference and Gene Delivery (14 papers), Nanoplatforms for cancer theranostics (8 papers), Antibiotic Resistance in Bacteria (7 papers), CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Phagocytosis and Immune Regulation (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). The work is most often cited by research in Molecular Medicine (165 citations), Immunology (497 citations) and Endocrinology (72 citations). Yingying Shi has collaborated with scholars based in China, Hong Kong and Czechia. Frequent co-authors include Jian You, Lihua Luo, Mengshi Jiang, Junlei Zhang, Yichao Lu, Bing Qin, Yingwei Chen, Mingxia Zhou, Zhenyu Luo and Chunqi Zhu. Their work appears in journals such as Nature Communications, Environmental Science & Technology and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.